Research and Markets (http://www.researchandmarkets.com/research/7ndsd4/smoking_cessation)
has announced the addition of the "Smoking
Cessation - Pipeline Review, H1 2014" report to their offering.
This report provides comprehensive information on the therapeutic
development for Smoking Cessation, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for Smoking
Cessation and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
For more information visit http://www.researchandmarkets.com/research/7ndsd4/smoking_cessation
[ Back To NFVZone's Homepage ]